Skip to main content
. 2015 May 21;9(2):136–143. doi: 10.1080/19336896.2015.1022020

TABLE 2.

Clinical characteristics of probable CJD and non-CJD subjects

  Probable CJD (n = 25) Non-CJD (n = 39) p-value
Age 64.74 ± 10.29 64.33 ± 12.33 0.89
Male 65% 40% <0.01
Presenting Symptoms      
 Mental change 0 (0) 10 (26) <0.01*
 Headache 6 (24) 8 (21) 0.74
 Psychiatric symptoms 3 (12) 5 (13) 0.99*
 Cognitive decline 5 (20) 4 (10) 0.46*
 Pyramidal/extrapyramidal 1 (4) 4 (10) 0.69*
 Cerebellar dysfunction 3 (12) 2 (5) 0.59*
 Seizure 2 (8) 2 (5) 0.99*
 Myoclonus 1 (4) 1 (3) 0.99*
 Visual disturbance 2 (8) 0 (0) 0.30*
 Dysarthria/speech 2 (8) 0 (0) 0.30*
Initial consciousness at admission      
 Alert 15 (60) 15 (38) 0.09
 Confusion 1 (4) 2 (5) 0.99*
 Drowsy 2 (8) 9 (23) 0.22*
 Stupor 3 (12) 12 (31) 0.08
 Semicoma 1 (4) 1 (3) 0.99*
EEG abnormality      
 Periodic wave 9 (36) 3 (8) 0.01*
 Epileptiform discharge 2 (8) 6 (15) 0.64*
 Slowing 11 (44) 21 (54) 0.44
Diffusion MRI abnormality      
 Caudate/putamen 10 (40) 2 (5) <0.01*
 Diffuse cortical 10 (40) 7 (18) 0.05
 Other 3 (12) 21 (54) <0.01

Mean ± standard deviations for continuous variables.

Parentheses denote percentages.

*

Fisher's Exact tests.

Abbreviation: CJD (Creutzfeldt-Jakob Disease), EEG (electroencephalography), MRI (magnetic resonance imaging).